Futura’s Revolutionary ED Treatment One Step Closer To US And EU OTC Approval
US and EU OTC approval for Futura's drug-free erectile dysfunction treatment MED3000 edges closer, following the company's submission of its EU dossier and a second pre-submission meeting with the FDA.
You may also be interested in...
Pfizer is investing roughly $10m in Viagra Connect in the UK to help raise awareness of erectile problems among the country's male population.
HBW Insight talks exclusively to Futura Medical about its new erectile dysfunction product MED3000, which it says could take the global OTC market by storm.
Perrigo is launching in the UK an OTC sildenafil generic to compete with Pfizer's erectile dysfunction drug Viagra Connect.